Quick Answer
MYRIAD GENETICS INC reported Stockholders Equity of $368.00 million for the year ending 2025.
- MYRIAD GENETICS INC showed a decrease of -47.5% in Stockholders Equity from 2024 to 2025.
- This data is from MYRIAD GENETICS INC's annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2009 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2010: $571.11 million | Q4 2010: $561.10 million | Q1 2011: $524.46 million | Q3 2011: $578.99 million | Q4 2011: $616.76 million | Q1 2012: $652.19 million | Q3 2012: $635.57 million | Q4 2012: $662.12 million | Q1 2013: $664.93 million | Q3 2013: $690.27 million | Q4 2013: $675.97 million | Q1 2014: $722.24 million | Q3 2014: $712.15 million | Q4 2014: $694.24 million | Q1 2015: $668.90 million | Q3 2015: $687.10 million | Q4 2015: $770.80 million | Q1 2016: $770.20 million | Q3 2016: $735.50 million | Q4 2016: $732.90 million | Q1 2017: $748.20 million | Q3 2017: $870.90 million | Q4 2017: $914.20 million | Q1 2018: $948.30 million | Q3 2018: $1.10 billion | Q4 2018: $1.06 billion | Q1 2019: $1.08 billion | Q3 2019: $1.07 billion | Q4 2019: $1.08 billion | Q1 2020: $967.20 million | Q2 2020: $918.20 million | Q3 2020: $909.30 million | Q1 2021: $875.20 million | Q2 2021: $902.50 million | Q3 2021: $968.60 million | Q1 2022: $950.10 million | Q2 2022: $947.40 million | Q3 2022: $916.60 million | Q1 2023: $835.20 million | Q2 2023: $735.20 million | Q3 2023: $683.40 million | Q1 2024: $760.00 million | Q2 2024: $740.50 million | Q3 2024: $731.70 million | Q1 2025: $704.90 million | Q2 2025: $388.10 million | Q3 2025: $372.80 million.
- Over the full 18 years of available data (2009 to 2025), MYRIAD GENETICS INC's Stockholders Equity has declined by 15.3%.
- Historical annual values: Fiscal year 2025: $368.00 million | Fiscal year 2024: $701.10 million | Fiscal year 2023: $783.20 million | Fiscal year 2022: $885.80 million | Fiscal year 2021: $967.80 million | Fiscal year 2020: $881.00 million | Fiscal year 2020: $918.20 million | Fiscal year 2019: $1.09 billion | Fiscal year 2018: $966.10 million | Fiscal year 2017: $768.40 million | Fiscal year 2016: $739.60 million | Fiscal year 2015: $661.70 million | Fiscal year 2014: $719.00 million | Fiscal year 2013: $728.60 million | Fiscal year 2012: $635.80 million | Fiscal year 2011: $566.79 million | Fiscal year 2010: $557.58 million | Fiscal year 2009: $434.22 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: